Sources | Names Used |
---|---|
CTRPv2 | BRD-K16147474 |
PharmacoGx | BRD-K16147474 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC30A1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | AGBL4 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | RORB | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | LYRM7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | PDCD5 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | MARVELD3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | SF3B6 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | MFAP2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RP11-111K18.1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | ABAT | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |